Yahoo Web Search

Search results

1. • 

     InnoCare Pharma concludes subject enrolment Phase II psoriasis trial

     Clinical Trials Arena via Yahoo Finance· 4 hours ago

     InnoCare Pharma has announced the completion of subject enrolment in the Phase II clinical trial of...

2. • 

     Bryhali dosage: Form, strength, how to use, and more

     Medical News Today· 6 days ago

     Bryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...

3. • Q1 2024 Arcutis Biotherapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 19 hours ago

     In February, we completed a secondary offering that raised $172 million gross proceeds, which along with net product revenues and our existing balance sheet puts us in a very strong financial ...

4. • Analyst Report: Biogen Inc

     Argus Research via Yahoo Finance· 19 hours ago

     The company is the market leader in multiple sclerosis drugs and launched the first approved treatments for spinal muscular atrophy and Alzheimer's disease. The company also sells products that ...

5. • AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts

     ETF DAILY NEWS· 10 hours ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued to clients and investors on Tuesday ...

6. • 

     Earnings call: Arcutis Biotherapeutics reports strong Q1 2024 growth

     Investing.com· 1 day ago

     Arcutis Biotherapeutics (NASDAQ: ARQT ) has announced robust financial results for the first quarter...

7. • 

     Stelara interactions: Other medications, alcohol, and more

     Medical News Today· 6 days ago

     Stelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....

8. • 

     Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'

     MedPage Today· 3 days ago

     An analysis of patent applications for 10 top-selling prescription drugs found that nearly...

9. • 

     It Took Me Years to Find the Right Psoriatic Arthritis Medication

     Verywell Health via Yahoo News· 2 days ago

     After being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...

10. • Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...

      FOX21 Colorado Springs· 7 days ago

      Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...